Secondary relevance to vitamin D This paper mainly addresses another topic and also reports a vitamin D analysis, result or scientific synthesis.
This paper mainly addresses another topic and also reports a vitamin D analysis, result or scientific synthesis.
Why this paper is included
Supporting source evidence:
On the basis of the current evidence, compared with healthy children, children with GP had lower serum 25-hydroxyvitamin D (25(OH)D) concentrations (SMD = −2.75, 95% CI: −3.46 to −2.04; P < 0.05) and lower bone density (Z value) (MD = −0.07, 95% CI: −0.12 to −0.02; P = 0.008).
Source: Abstract. View original paper
Relevance classification does not establish study quality, causation or editorial approval.
Study design Systematic review.
Systematic review
Uses explicit methods to identify, assess and summarise research on a defined question.
Meta-analysis reported · Blinding not applicable to this review · Research setting awaiting verification
How this paper was classified
Automatic source-based classification; awaiting editorial verification. This is not a quality score.
Risk factors associated with growth pain disorder in children: a systematic review and meta-analysis
Source: Article title.
Risk factors associated with growth pain disorder in children: a systematic review and meta-analysis
Source: Article title.
What the study types mean
- Systematic review
- Uses explicit methods to identify, assess and summarise research on a defined question.
- Scoping review
- Maps the extent and characteristics of research on a topic.
- Narrative review
- Discusses existing research; systematic-review methods have not been established by this classification.
- Review / evidence synthesis
- Reviews existing research; the exact review methods need further assessment.
- Randomised controlled trial
- Assigns participants or groups to comparison interventions by chance.
- Non-randomised intervention study
- Examines an intervention without random allocation.
- Cohort study
- Examines exposures and outcomes over time within a defined group.
- Case-control study
- Compares people with an outcome against people without it, examining exposures.
- Cross-sectional study
- Examines a population at a particular point in time.
- Observational study
- Observes exposures and outcomes without assigning the exposure; the subtype is not established here.
- Case report
- Describes an individual case.
- Case series
- Describes a group of individual cases.
- Secondary analysis
- Analyses existing study data; this paper is not automatically another independent trial.
- Laboratory study
- Investigates biological processes in a laboratory setting.
- Qualitative study
- Examines experiences or meanings using qualitative methods.
- Genetic instrumental-variable study
- Uses genetic variation as an instrument to investigate relationships; this is not a randomised treatment trial.
- Study protocol
- Describes planned methods and is not evidence that the planned study has reported results.
- Multiple reported designs
- More than one design is explicitly reported; examine the supporting methods.
- Study design awaiting verification
- The available source does not establish a sufficiently clear study design.
Meta-analysis combines numerical results from studies. Blinding describes who was unaware of treatment allocation. Neither is a separate quality grade. Study design, vitamin D relevance and document format are independent filters.
Abstracts
Risk factors associated with growth pain disorder in children: a systematic review and meta-analysis
Systematic review · Frontiers in Pediatrics · 2026
Original publication title
Risk factors associated with growth pain disorder in children: a systematic review and meta-analysis
© 2026 Luo, Huang, Guo and Lian.
Original publication · Publisher record · CC BY 4.0
Source wording retained. Formatting, section navigation and display-title punctuation adapted for this research record.
At a glance
Abstract: What objectives does the paper state?
To systematically evaluate the risk factors associated with growth pain disorder (GP) in children and provide an evidence-based reference for its clinical diagnosis and intervention.
Source: ObjectiveAbstract: What methods does the paper describe?
Seven electronic databases were searched from database inception to Oct 2025 to identify clinical studies investigating risk factors for GP in children. Two researchers independently screened the literature, extracted the data, and assessed the study quality. Statistical analyses were performed using Review Manager (version 5.4), and descriptive analyses were conducted for studies that could not be statistically analyzed.
Source: MethodsAbstract: Systematic Review Registration
PROSPERO CRD420251150931.
Source: Systematic Review RegistrationAbstract: Results
A total of 37 studies involving 16,086 participants and reporting 17 potential risk factors were included. On the basis of the current evidence, compared with healthy children, children with GP had lower serum 25-hydroxyvitamin D (25(OH)D) concentrations (SMD = −2.75, 95% CI: −3.46 to −2.04; P < 0.05) and lower bone density (Z value) (MD = −0.07, 95% CI: −0.12 to −0.02; P = 0.008). Hypermobility/physical activity (OR = 1.34; 95% CI: 1.14 to 1.58; P < 0.001) might be correlated with the occurrence of GP, and overactivity and joint hypermobility are more prevalent among children with GP.
Genetic or family history and psychosocial status seem to play a role in disease onset. Compared with healthy children, children with GP appeared to have lower pain thresholds and a greater number of pain points. Evidence regarding the effects of perinatal factors, breastfeeding, and picky eating on GP remains limited, and further studies are needed to prove the correlation of these factors with GP. No evidence supporting a connection between GP and bed-sharing, vascular perfusion patterns, fatty acid status, or rapid growth has been reported.
Source: ResultsAbstract: Conclusion
GP in children is affected by multiple factors, and our study offers a valuable reference for clinical diagnosis and treatment. However, owing to the heterogeneity and sample size of the included studies, the results should be interpreted with caution. More high-quality prospective studies are needed to further strengthen our understanding of the factors influencing GP in children.
Source: ConclusionAuthors’ abstract
Objective
To systematically evaluate the risk factors associated with growth pain disorder (GP) in children and provide an evidence-based reference for its clinical diagnosis and intervention.
Methods
Seven electronic databases were searched from database inception to Oct 2025 to identify clinical studies investigating risk factors for GP in children. Two researchers independently screened the literature, extracted the data, and assessed the study quality. Statistical analyses were performed using Review Manager (version 5.4), and descriptive analyses were conducted for studies that could not be statistically analyzed.
Results
A total of 37 studies involving 16,086 participants and reporting 17 potential risk factors were included. On the basis of the current evidence, compared with healthy children, children with GP had lower serum 25-hydroxyvitamin D (25(OH)D) concentrations (SMD = −2.75, 95% CI: −3.46 to −2.04; P < 0.05) and lower bone density (Z value) (MD = −0.07, 95% CI: −0.12 to −0.02; P = 0.008). Hypermobility/physical activity (OR = 1.34; 95% CI: 1.14 to 1.58; P < 0.001) might be correlated with the occurrence of GP, and overactivity and joint hypermobility are more prevalent among children with GP.
Genetic or family history and psychosocial status seem to play a role in disease onset. Compared with healthy children, children with GP appeared to have lower pain thresholds and a greater number of pain points. Evidence regarding the effects of perinatal factors, breastfeeding, and picky eating on GP remains limited, and further studies are needed to prove the correlation of these factors with GP. No evidence supporting a connection between GP and bed-sharing, vascular perfusion patterns, fatty acid status, or rapid growth has been reported.
Conclusion
GP in children is affected by multiple factors, and our study offers a valuable reference for clinical diagnosis and treatment. However, owing to the heterogeneity and sample size of the included studies, the results should be interpreted with caution. More high-quality prospective studies are needed to further strengthen our understanding of the factors influencing GP in children.
Systematic Review Registration
PROSPERO CRD420251150931.
Publication and source details
Original title: Risk factors associated with growth pain disorder in children: a systematic review and meta-analysis
Ting Luo; Yutong Huang; Yixin Guo; Xianghong Lian
Frontiers in Pediatrics · 2026
* Correspondence: Xianghong Lian 1026687240@qq.com© 2026 Luo, Huang, Guo and Lian.2026Luo, Huang, Guo and Lianhttps://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.The author(s) declared that financial support was not received for this work and/or its publication.Repository JATS snapshot; version as supplied
Source retrieved: 2026-11-10T22:30:22.172899+00:00
DOI: 10.3389/fped.2026.1806380 · PMC13223011